Enanta Pharmaceuticals Inc 10-K for FY2021
Enanta Pharmaceuticals Inc (ENTA)
10-K
2021-11-24
For: 2021-09-30
View Original
Added on
April 06, 2026
About this 10-K
Enanta Pharmaceuticals Inc filed this 10-K on November 24, 2021, covering the fiscal year ended September 30, 2021 (FY2021).
Headline figures
Fiscal year ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $97.07M
- down 20.7% from $122.47M a year earlier
- Net loss
- $79M
- compared with a net loss of $36.17M a year earlier
- Diluted EPS
- -$3.92
- compared with -$1.81 a year earlier